Imagion Biosystems Financial Data

Nome Compagnia:Imagion Biosystems LtdStatus:Active
End of fiscal year:31 Dicembre 2018ISINAU000000IBX6
Year established:2016Company sector name:Healthcare
Trading currency:AUDIndustry name:Diagnostics & Research
Place of incorporation:Australia (AU)Industry group nameMedical Diagnostics & Research
Doing business in:United States (US)Address10355 Science Center Drive
Suite 210, 92121
Tel.:+1 855 564-5264City/Country:San Diego, United States
Web address:http://www.imagionbiosystems.com
Descrizione Attività:Imagion Biosystems Ltd operates in the field of non-invasive detection of specific solid tumor cancers by use of magnetic nanoparticles. The company only operating segment - Research and Development. Its principal business activities consist of nanotechnology, biotechnology, cancer diagnostics, and superparamagnetic relaxometry. In addition, the company is engaged in the research and development of its clinical phase lead product which is intended for the detection and staging of metastatic HER2 breast cancer.
Prezzo Variazione [%] Denaro Lettera Aper Max Min Volume
0,068  -0,001[-1,45%] 0,068 0,069 0,069 0,071 0,068 4.134.621
Cap. di mercato [m] Azioni circolanti [m] Beta EPS DPS PE Ratio Yield Oscillazione-52-Settimane
15.240970263 322.742824 - -0,04 - -1,83 - 0,06 - 0,23

IBX KEY FIGURES (at previous day's close)

Yesterday's Close
0,07
PE Ratio
-1,83
Market Capitalisation
15,24M
Latest Shares Outstanding
322,74M
Earnings pS (EPS)
-0,04
Dividend pS (DPS)
-
Dividend Yield
-
Sales per Employee
-
Effective Tax Rate
-
Foreign Sales
-
Domestic Sales
-
Selling, General & Adm/tive (SG...
2.070,96%
Research & Devlopment (R&D) as ...
0,00%
Gross Profit Margin
100,00%
EBITDA Margin
-
Pre-Tax Profit Margin
-
Assets Turnover
27,09%
Return on Assets (ROA)
-1,30%
Return on Equity (ROE)
-1,54%
Return on Capital Invested (ROC...
-1,53%
Current Ratio
3,78
Leverage Ratio (Assets/Equity)
1,34%
Interest Cover
-1.047,14
Total Debt/Equity (Gearing Rati...
0,01%
LT Debt/Total Capital
0,00%
Working Capital pS
0,02
Cash pS
0,02
Book-Value pS
0,02
Tangible Book-Value pS
0,00
Cash Flow pS
-
Free Cash Flow pS
-0,03
Spread
0,00
Gross gearing
0,00%
Net Debt
-4,37M

IBX Balance Sheet Chart (30 Dicembre 2018)

:liab eq:assets
Periodo † Max Min
1 Sett.0,0710,067
1 Mese0,080,067
3 Mesi0,110,065
6 Mesi0,180,065
1 Anno0,2250,064
3 Anni0,2250,01
5 Anni0,2250,00

Share price performance previous 3 years

Share price performance intraday

Periodo † Apert. Open Avg. VWAP Vol Min Vol Max Med. Vol. Giorn. Var %
1 Sett.0,0710,06820,0681512.051.2136.600.8733.852.097-0,003-4,23%
1 Mese0,080,07230,071898991.3046.739.6623.266.445-0,012-15,0%
3 Mesi0,0990,0810740,078961991.30421.331.1364.833.423-0,031-31,31%
6 Mesi0,170,1026340,098243991.30471.008.3626.658.480-0,102-60,0%
1 Anno0,090,1162470,11832991.30471.008.3627.910.676-0,022-24,44%
3 Anni0,060,0679630,076954200139.751.5227.514.5670,00813,33%
5 Anni0,180,0770970,077217200139.751.5225.486.351-0,112-62,22%

IBX Growth Ratios (30 Dicembre 2018)

1 year 3 years 5 years 10 years
Diluted EPS growth
-
-
-
-
Diluted continuous EPS growth
-
-
-
-
Dividend growth
-
-
-
-
Equity per share growth
-0,60
-
-
-
Revenue growth
8,53
-
-
-
Operating income growth
-
-
-
-
Net income growth
-
-
-
-
Net income cont growth
-
-
-
-
CFO growth
-
-
-
-
FCF growth
-
-
-
-
Operating revenue growth
8,53
-
-
-

IBX Income Statement 30 Dicembre 2018 (AUD)

Total Revenue
0.191477
Operating Revenue
0.191477
Gross Profit
0.191477
Operating Expenses
9.148641
Selling,General and Administr...
3.965413
General and Administrative Ex...
3.965413
Salary and Benefit
3.965413
Research and Development
3.295676
Depreciation,Amortization and...
0.213791
Depreciation and Amortization
0.213791
Depreciation
0.213791
Other Operating Expenses
1.673761
Operating Income
-8.957164
Interest Income/Expense,Net-N...
0.029202
Interest Income-Non Operating
0.036955
Interest Expense-Non Operatin...
7.753,00
Other Income/Expense,Net
0.587949
Other Non-Operating Income/Ex...
0.587949
Pretax Income
-8.340013
Provision for Income Tax
0,00
Net Income Available to Commo...
-8.340013
Net Income
-8.340013
Net Income Including Noncontr...
-8.340013
Net Income from Continuing Op...
-8.340013
Basic EPS
-0,04
Basic EPS from Continuing Ope...
-0,04
Basic EPS from Discontinued O...
0,00
Diluted EPS
-0,04
Diluted EPS from Continuing O...
-0,04
Diluted EPS from Discontinued...
0,00
Basic Weighted Average Shares...
220.883627
Diluted Weighted Average Shar...
220.883627
Net Income from Continuing an...
-8.340013
Normalized Income
-8.340013
Basic EPS,Continuing and Disc...
-0,04
Diluted EPS,Continuing and Di...
-0,04
Interest and Dividend Income
0.036955
Interest Expense
7.753,00
Net Interest Income
0.029202
Earning Before Interest and T...
-8.33226
Earning Before Interest Tax D...
-8.118469
Depreciation,Reconciled
0.213791
Net Income from Continuing Op...
-8.340013
Normalized Basic EPS
-0,04
Normalized Diluted EPS
-0,04
NormalizedEBITDA
-8.118469
Tax rate for calculations
0,00

IBX Efficency Ratios (30 Dicembre 2018)

Days in sales
142,19
Days in inventory
-
Days in payment
-
Cash conversion cycle
-
Receivable turnover
2,57
Inventory turnover
-
Payable turnover
-
Fixed assets turnover
0,59
Assets turnover
0,03
ROE
-1,54
ROA
-1,30
ROIC
-1,53
FCF sales ratio
-
FCF net income ratio
-
Capital expenditure sales ratio
0,44

IBX Financial Health Ratios (30 Dicembre 2018)

Current ratio
3,78
Quick ratio
3,74
Debt total capital ratio
0,00
Debt equity ratio
0,00
Financial leverage
1,34
Total debt to equity
0,01

IBX Avearge Growth Ratios Over 5 Years (30 Dicembre 2018)

Growth ann capital spending
-
Growth ann gross profit
-
Avg gross margin
-
Avg post tax margin
-
Avg pre tax marginr
-
Avg net profit
-
Avg ret commonr
-
Avg ret assets
-
Avg ret invested capital
-

IBX Profitability Ratios (30 Dicembre 2018)

Gross margin
1,00
Operating margin
-46,78
EBT margin
-43,56
Tax rate
-
Net margin
-43,56
Sales per employee
-
EBIT margin
-43,52
EBITDA margin
-42,40
Normalized net profit margin
-43,56
Interest coverage
-1.074,71
Inc per employee tot ops
-

IBX Valuation Ratios (31 Dicembre 2018)

Sales per share
0,00
Growth ann sales per share 5 ye...
-
Book value per share
0,01
CF per share
-0,04
Price to EPS
-
Ratio PE 5 year high
-
Ratio PE 5 year low
-
Price to book
2,59
Price to sales
175,44
Price to cash flow
-
Price to free cash flow
-
Div rate
-
Dividend yield
-
Div payout tot ops
-
Div payout 5 year
-
Payout ratio
0,00
Sustainable growth rate
-0,84
Cash return
-2,18

IBX Balance Sheet 30 Dicembre 2018 (AUD)

Total Assets
5.187459
Current Assets
4.915599
Cash,Cash Equivalents,and Sho...
4.367097
Cash and Cash Equivalents
4.367097
Cash
4.367097
Receivables
0.495617
Accounts Receivable
0.140481
Other Receivables
0.355136
Prepaid Assets and Others
0.052885
Total Non-Current Assets
0.27186
Net Property,Plant,and Equipm...
0.27186
Gross Property,Plant,and Equi...
1.32826
Machinery,Furniture/Equipment
1.32826
Accumulated Depreciation
-1.0564
Total Liabilities
1.318231
Current Liabilities
1.299797
Payables and Accrued Expenses
1.187992
Payables
1.187992
Accounts Payable
0.98368
Other Payable
0.204312
Pension and Other Post-Retire...
0.075723
Current Debt and Capital Leas...
0.036082
Current Portion of Capital Le...
0.036082
Total Non-Current Liabilities
0.018434
Long Term Debt and Capital Le...
0.018434
Long Term Portion of Capital ...
0.018434
Total Equity
3.869228
Stockholder's Equity
3.869228
Capital Stock
33.182325
Common Stock
33.182325
Retained Earnings
-31.213035
Accumulated Gains/ Losses Not...
1.899938
Foreign Currency Translation ...
0.102946
Other Equity Adjustments
1.796992
Total Capitalization
3.869228
Common Stock Equity
3.869228
Capital Lease Obligations
0.054516
Net Tangible Assets
3.869228
Working Capital
3.615802
Invested Capital
3.869228
Tangible Book Value
3.869228
Total Debt
0.054516
Ordinary Shares Number
322.742824
TotalLiabilitiesAsReported
1.318231
TotalEquityAsReported
3.869228

IBX Cash Flow 30 Dicembre 2018 (AUD)

Classes of Cash Receipts from...
0.154457
Receipts from Customers
0.154457
Classes of Cash Payments
-6.786076
Payments to Suppliers for Goo...
-6.786076
Interest Paid, Direct
-2.669,00
Interest Received, Direct
0.067078
Cash Flow from Investing Acti...
-0.083565
Cash Flow from Continuing Inv...
-0.083565
Purchase/Sale of Property,Pla...
-0.083565
Purchase of Property,Plant an...
-0.083565
Cash Flow from Financing Acti...
4.103202
Cash Flow from Continuing Fin...
4.103202
Issuance/Payments of Common S...
4.231695
Proceeds or Issuance of Commo...
4.285884
Payments for Common Stock
-0.054189
Other Financing Changes, Net
-0.128493
Cash and Cash Equivalents,End...
4.367097
Change in Cash
-2.547573
Effect of Exchange Rate Chang...
0.041841
Cash and Cash Equivalents,Beg...
6.872829
Interest Paid, Supplemental D...
2.669,00
Capital Expenditure
-0.083565
Issuance of Capital Stock
4.285884
Repurchase of Capital Stock
-0.054189
Free Cash Flow
-6.650775
ChangeinCashSupplementalAsRep...
-2.547573
La tua Cronologia
BIT
BMPS
Monte Pasc..
BITI
FTSEMIB
FTSE Mib
BIT
UCG
Unicredit
NASDAQ
AAPL
Apple
FX
EURUSD
Euro vs Do..
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.

Registrati ora per creare la tua watchlist personalizzata in tempo reale streaming.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

P: V: D:20210916 19:55:28